These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12548382)

  • 21. [Type II oculo-cutaneous tyrosinosis or Richner-Hanhart syndrome--apropos of a case].
    Foels MO; Dufier JL; Renard G; Gounod N; D'Hermies F; Pouliquen Y
    Bull Soc Ophtalmol Fr; 1989 Jan; 89(1):21-4. PubMed ID: 2574638
    [No Abstract]   [Full Text] [Related]  

  • 22. Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II).
    Paige DG; Clayton P; Bowron A; Harper JI
    J R Soc Med; 1992 Dec; 85(12):759-60. PubMed ID: 1362969
    [No Abstract]   [Full Text] [Related]  

  • 23. Type I hereditary tyrosinaemia: presentation of 11 cases.
    Coşkun T; Ozalp I; Koçak N; Yüce A; Caglar M; Berger R
    J Inherit Metab Dis; 1991; 14(5):765-70. PubMed ID: 1664010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of diet on the ophthalmological, clinical and biochemical aspects of Richner-Hanhart syndrome: a morphological ultrastructural study of the cornea and the conjunctiva.
    Sammartino A; Cerbella R; Cecio A; De Crecchio G; Federico A; Fronterre A
    Int Ophthalmol; 1987 Aug; 10(4):203-12. PubMed ID: 3654059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incurable keratitis and chronic palmoplantar hyperkeratosis with hypertyrosinemia. Cure using a tyrosine-restricted diet. Type II tyrosinemia].
    Hervé F; Moreno JL; Ogier H; Saudubray JM; De Prost Y; Duffier JL; Charpentier C; Lemonnier F; Frézal J
    Arch Fr Pediatr; 1986 Jan; 43(1):19-22. PubMed ID: 2939812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudoherpetic keratitis. Corneal changes in circumscribed palmo-plantar keratoderma.
    Westmore R; Billson FA
    Br J Ophthalmol; 1973 Sep; 57(9):654-6. PubMed ID: 4757338
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary succinylacetone presence and delta-aminolaevulinic acid excretion in patients with type I tyrosinaemia during treatment.
    Pronicka E; Mielniczuk Z; Rowińska E; Ksiazyk J; Szczygielska-Kozak M; Wieczorek E; Kulczycka H
    Mater Med Pol; 1991; 23(2):136-8. PubMed ID: 1842600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion.
    Iskeleli G; Bilgeç MD; Arici C; Atalay E; Oğreden T; Aydin A
    Turk J Pediatr; 2011; 53(6):692-4. PubMed ID: 22389994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful dietary control of tyrosinemia II.
    Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H
    J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and therapy of 6 inherited, metabolic diseases, leading to mental deficiency. 1].
    Menne F; Enzenauer J; Matz D
    Med Klin; 1976 Apr; 71(17):724-8. PubMed ID: 775276
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tyrosinosis].
    Halvorsen S
    Monatsschr Kinderheilkd (1902); 1969 Jan; 117(1):31-2. PubMed ID: 5398915
    [No Abstract]   [Full Text] [Related]  

  • 32. Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia.
    Holme E; Lindblad B; Lindstedt S
    Lancet; 1985 Mar; 1(8427):527. PubMed ID: 2857895
    [No Abstract]   [Full Text] [Related]  

  • 33. Prenatal diagnosis of tyrosinaemia type I by use of stable isotope dilution mass spectrometry.
    Jakobs C; Kvittingen EA; Berger R; Haagen A; Kleijer W; Niermeijer M
    Eur J Pediatr; 1985 Jul; 144(2):209-10. PubMed ID: 4043138
    [No Abstract]   [Full Text] [Related]  

  • 34. Mental retardation in a family with phenylketonuria and mild hyperphenylalaninemia.
    Cohen BE; Szeinberg A; Berman W; Aviad Y; Crispin M; Hirshorn N; Goland R
    Pediatrics; 1969 Nov; 44(5):655-60. PubMed ID: 5374976
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tyrosinemia II].
    Kalimo K; Ivaska K; Koistinen T; Havu VK
    Duodecim; 1985; 101(16):1585-9. PubMed ID: 2865123
    [No Abstract]   [Full Text] [Related]  

  • 36. [Type II oculo-cutaneous tyrosinosis].
    Gounod N; Ogier H; Dufier JL; Larrègue M; Saudubray JM; de Prost Y
    Ann Dermatol Venereol; 1984; 111(8):697-8. PubMed ID: 6152137
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic imaging with computed tomography of chronic tyrosinaemia type 1.
    Macvicar D; Dicks-Mireaux C; Leonard JV; Wight DG
    Br J Radiol; 1990 Aug; 63(752):605-8. PubMed ID: 2400875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two cases of Richner-Hanhart syndrome (oculocutaneous tyrosinemia)].
    Bygum A; Brandrup F; Gade EF; Lund AM; Christensen E
    Ugeskr Laeger; 2008 Feb; 170(8):655. PubMed ID: 18364160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia.
    Suzuki Y; Konda M; Imai I; Imamura H; Shimao S; Okaka T
    Int J Pediatr Nephrol; 1987; 8(3):171-6. PubMed ID: 3429140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.